An official website of the United States government
Publication Information
Affiliation
Tufts Medical Center, Boston, MA. Electronic address: linker@tuftsmedicalcenter.org.; Tufts Medical Center, Boston, MA; Research Design Center/Biostatistics Research Center, Tufts CTSI and Institute for Clinical Research and Health Policy Studies, Boston, MA.; Johns Hopkins University School of Medicine, Baltimore, MD.; Tufts Medical Center, Boston, MA.; Perelman School of Medicine at the University of Pennsylvania. Philadelphia, PA.; Cleveland Clinic, Cleveland, OH.; University of Miami Miller School of Medicine, Miami, FL.; University of Utah, Salt Lake City, UT.; University of Minnesota, Minneapolis, MN.; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.; University of Illinois at Chicago, Chicago, IL.; Vanderbilt Medical Center, Nashville, TN.; Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH.; Cleveland Clinic, Cleveland, OH.; Wayne State University, Detroit, MI.; Johns Hopkins University School of Medicine, Baltimore, MD.; Tufts Medical Center, Boston, MA.
Authors
Inker Lesley A, Tighiouart Hocine, Coresh Josef, Foster Meredith C, Anderson Amanda H, Beck Gerald J, Contreras Gabriel, Greene Tom, Karger Amy B, Kusek John W, Lash James, Lewis Julia, Schelling Jeffrey R, Navaneethan Sankar D, Sondheimer James, Shafi Tariq, Levey Andrew S
Studies
Abstract
β-Trace protein (BTP) and β2-microglobulin (B2M) are novel glomerular filtration markers that have stronger associations with adverse outcomes than creatinine. Comparisons of BTP and B2M to creatinine and cystatin C are limited by the absence of rigorously developed glomerular filtration rate (GFR) estimating equations for the novel markers.